BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18841419)

  • 1. Venous thromboembolism in cancer patients undergoing major surgery.
    Osborne NH; Wakefield TW; Henke PK
    Ann Surg Oncol; 2008 Dec; 15(12):3567-78. PubMed ID: 18841419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.
    ten Cate-Hoek AJ; Prins MH
    Thromb Res; 2008; 122(5):584-98. PubMed ID: 17996281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative venous thromboembolism prophylaxis in Israel: a survey of academic surgical departments.
    Ellis MH; Elis A
    Eur J Haematol; 2004 Aug; 73(2):104-8. PubMed ID: 15245509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advancement of prophylaxis and therapy for venous thromboembolism].
    Kobayashi T
    Rinsho Byori; 2008 Jul; 56(7):589-99. PubMed ID: 18709991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer.
    Lee AY
    Thromb Res; 2007; 120 Suppl 2():S121-7. PubMed ID: 18023705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of venous thromboembolism in cancer patients.
    Petralia GA; Kakkar AK
    Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
    Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM
    Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin in oncology.
    Zacharski LR; Loynes JT
    Anticancer Res; 2003; 23(3C):2789-93. PubMed ID: 12926114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in cancer patients: expanding horizons.
    Bergqvist D
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():19-23. PubMed ID: 12232819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
    Burris HA
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    White RH; Chew H; Wun T
    Thromb Res; 2007; 120 Suppl 2():S29-40. PubMed ID: 18023711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis.
    Bergqvist D
    J Surg Oncol; 2007 Feb; 95(2):167-74. PubMed ID: 17262765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients.
    Bergqvist D
    Dis Colon Rectum; 2006 Oct; 49(10):1620-8. PubMed ID: 17019655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.